SpectRx' BiliCheck
This article was originally published in The Gray Sheet
Executive Summary
510(k) is filed for the non-invasive bilirubin analyzer, which the company claims provides comparable results to blood tests in less than a minute by shining and analyzing light beams on an infant's forehead. Launched overseas in May, the product was cleared in Canada on June 29 ("The Gray Sheet" July 13, In Brief)
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.